Post-operative systemic chemo and RT did not improve OS in high-risk patients with stage I endometrial cancer, according to Rachelle Findley, MD, et al.
Teresa Boitano, MD, discusses an analysis comparing minimally-invasive hysterectomy vs open radical hysterectomy for early-stage cervical cancer.
Findings from a study presented at the 2021 SGO Virtual Annual Meeting on Women's Cancer, frail patients with ovarian cancer who undergo surgery at institutions with higher surgical volume have lower…
In a session presented at the 2021 SGO Annual Meeting on Women’s Cancer Rebecca Kristeleit, PhD, UCL Cancer Institute, London, shared findings from the ARIEL4 study on rucaparib versus chemotherapy.
Durvalumab plus PLD has shown promising efficacy in patients with platinum-resistant recurrent ovarian cancer.
Restrictive prescribing can significantly reduce opioid use in patients with gynecologic cancers, all the while maintaining high patient pain management satisfaction.
Findings from a phase 2 study showed that adding pazopanib to gemcitabine enhanced antitumor activity in patients with ovarian cancer.
Stay in the know.
OncNet Newsletter